Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-05

FDA Approved: OXAZEPAM — Supplemental Application (TruPharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for Oxazepam from TruPharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXAZEPAM (OXAZEPAM)

Snippet

SUPPL AP for OXAZEPAM (OXAZEPAM)